News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ALK-Abello A/S’s 2014 Outlook Positively Impacted By German Price Reform



1/2/2014 9:13:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): The new German government has decided to partially revoke the AMNOG pricing act introduced in 2010. Amongst other things, the pricing act entailed a mandatory 16% sales rebate for all prescription drugs and a moratorium fixing prices at 2009 levels. According to the new legislation, the rebate will be reduced to 7% with effect from 1 January 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES